Risperdal M-tab Tablet, Orally Disintegrating
Product Images NDC 50458-355
Product Visual Gallery
This gallery contains 33 technical images submitted to the FDA as part of the official labeling for Risperdal M-tab (NDC 50458-355). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Janssen Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Risperdal 02)
Figure 2 (Risperdal 03)
Figure 3 (Risperdal 04)
Figure 4 (Risperdal 05)
Figura 4 (Risperdal 05a)
Risperdal 05b
Risperdal 05c
Risperdal 05d
Risperdal 05e
Risperdal 05f
Risperdal 05g
Risperdal 05h
Risperdal 05i
Risperdal 05j
Risperdal 05k
Risperdal 05l
Risperdal 05m
Risperdal 05n
Risperdal 05o
Risperdal 05p
Principal Display Panel (0.25 mg Bottle Label)
Principal Display Panel (0.5 mg Bottle Label)
Principal Display Panel (1 mg Bottle Label)
Principal Display Panel (2 mg Bottle Label)
Principal Display Panel (3 mg Bottle Label)
Principal Display Panel (4 mg Bottle Label)
Principal Display Panel (0.5 mg Tablet Carton)
Principal Display Panel (1 mg Tablet Carton)
Principal Display Panel (2 mg Tablet Carton)
Principal Display Panel (3 mg Tablet Carton)
Principal Display Panel (4 mg Tablet Carton)
Principal Display Panel (30 mL Bottle Carton)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.